Premium
Delayed treatment of 6‐Bromoindirubin‐3′‐oxime stimulates neurogenesis and functional recovery after focal ischemic stroke in mice
Author(s) -
Wang LiLi,
Li Jimei,
Gu Xiaohuan,
Wei Ling,
Yu Shan Ping
Publication year - 2017
Publication title -
international journal of developmental neuroscience
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.761
H-Index - 88
eISSN - 1873-474X
pISSN - 0736-5748
DOI - 10.1016/j.ijdevneu.2017.01.002
Subject(s) - neurogenesis , subventricular zone , neuroblast , doublecortin , ischemia , neuroprotection , neun , gsk 3 , gsk3b , stroke (engine) , neuroscience , biology , medicine , hippocampus , stem cell , neural stem cell , microbiology and biotechnology , dentate gyrus , signal transduction , immunohistochemistry , mechanical engineering , engineering
Glycogen synthase kinase 3β (GSK3β) was originally identified as a regulator for glycogen metabolism and is now an important therapeutic target for a variety of brain disorders including neurodegenerative diseases due to it's pivotal role in cellular metabolism, proliferation and differentiation. In the development of stroke therapies focusing on tissue repair and functional recovery, promoting neurogenesis is a main approach in regenerative medicine. In the present investigation, we explored the effects of a GSK3β specific inhibitor, 6‐Bromoindirubin‐3′‐oxime (BIO), on regenerative activities of neuroblasts in the subventricular zone (SVZ) and functional recovery after focal cerebral ischemia. Adult C57/BL mice were subjected to occlusion of distal branches of middle cerebral artery (MCA) supplying the sensorimotor barrel cortex. Three days later, BIO (8.5 μg/kg, i.p.) was administered every 2 days until sacrificed at 14 or 21 days after stroke. The BIO treatment significantly increased generation of neuroblasts labeled with BrdU and BrdU/doublecortin (DCX) in the SVZ. Comparing to vehicle controls, increased number of neuroblasts migrated to the peri‐infarct region where they differentiate into mature neurons. Along with the elevated BDNF expression at the peri‐infarct area, the number of newly formed neurons was significantly increased. BIO treatment significantly enhanced sensorimotor functional recovery after the focal ischemia. It is suggested that the GSK3 signaling may be a potential therapeutic target for regenerative treatment after ischemic stroke.